Reopening Hopes, Stocks Rise for Second Day, Starbucks Opening Plans, Vaccine Testing

Carl Quintanilla, Jim Cramer and David Faber discuss the pop in stocks for the second day in a row. Investors looking toward a more hopeful picture for reopening the economy. Pfizer is beginning human testing for its experimental coronavirus vaccine in the U.S. The company is working alongside German drugmaker BioNTech, saying the first human participants in the U.S. have been dosed with the potential vaccine. Starbucks announcing its plans to reopen more than 85% of its U.S. stores by the end of this week. It initially won’t allow dine-in service, but will provide pickup and delivery in cafes, as well as drive-through. By early June, the company expects to have more than 90% of its stores open with limited hours. Plus, WeWork co-founder Adam Neumann is going after Softbank, suing them over its failed tender offer.